Effects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene

被引:6
作者
Borgland, SL
Castañón, M
Spevak, W
Parkinson, FE
机构
[1] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0T6, Canada
[2] Boehringer Ingelheim R&D, Dept Mol Biol, Vienna, Austria
关键词
adenosine receptors; nucleoside transport; propentofylline;
D O I
10.1139/cjpp-76-12-1132
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Propentofylline is neuroprotective in vivo; but its mechanism of action is not completely understood. Previously, propentofylline was shown to black: adenosine transport processes, to inhibit three adenosine receptor subtypes, and to inhibit cAMP phosphodiesterase. We tested the effect of propentofylline on adenosine receptor function in Chinese hamster ovary (CHO) cells transfected with human adenosine A(1), A(2A), or A(2B) receptors and a luciferase reporter gene under control of a promoter sequence containing several copies of the cAMP response element. We investigated the concentration-dependent inhibitory effects of propentofylline on cAMP phosphodiesterase, adenosine transport processes, and adenosine A(1), A(2A), and A(2B) receptors. At concentrations greater than or equal to 1 mM, propentofylline increased luciferase activity probably as a result of inhibition of cAMP phosphodiesterase. Inhibition of [H-3]adenosine uptake by propentofylline was concentration dependent, with IC50 values of 37-39 mu M for the three cell types. Agonist-activated adenosine A(1) receptors were antagonized by 100 mu M propentofylline, but inhibition of agonist-stimulated A(2A) or A(2B) receptors was not observed. In contrast, A(1) and A(2A) receptor mediated effects of adenosine were enhanced by propentofylline at concentrations of 1 and 100 mu M, respectively. These data indicate that the net effects of propentofylline in vivo will be dependent on the concentrations of propentofylline and adenosine available and on the subtypes of adenosine receptors, phosphodiesterases, and nucleoside transporters present.
引用
收藏
页码:1132 / 1138
页数:7
相关论文
共 30 条
[11]   FURTHER EVIDENCE THAT PROPENTOFYLLINE (HWA-285) INFLUENCES BOTH ADENOSINE RECEPTORS AND ADENOSINE TRANSPORT [J].
FREDHOLM, BB ;
FASTBOM, J ;
KVANTA, A ;
GERWINS, P ;
PARKINSON, F .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1992, 6 (03) :99-111
[12]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143
[13]   EXTRACELLULAR ADENOSINE, INOSINE, HYPOXANTHINE, AND XANTHINE IN RELATION TO TISSUE NUCLEOTIDES AND PURINES IN RAT STRIATUM DURING TRANSIENT ISCHEMIA [J].
HAGBERG, H ;
ANDERSSON, P ;
LACAREWICZ, J ;
JACOBSON, I ;
BUTCHER, S ;
SANDBERG, M .
JOURNAL OF NEUROCHEMISTRY, 1987, 49 (01) :227-231
[14]  
HAGBERG H, 1990, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1990, P427
[15]   FUNCTIONAL TESTING OF HUMAN DOPAMINE-D1 AND DOPAMINE-D5 RECEPTORS EXPRESSED IN STABLE CAMP-RESPONSIVE LUCIFERASE REPORTER CELL-LINES [J].
HIMMLER, A ;
STRATOWA, C ;
CZERNILOFSKY, AP .
JOURNAL OF RECEPTOR RESEARCH, 1993, 13 (1-4) :79-94
[16]   Adenosine A3 receptors:: novel ligands and paradoxical effects [J].
Jacobson, KA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (05) :184-191
[17]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[18]   PHOSPHODIESTERASE INHIBITORY PROFILE OF SOME RELATED XANTHINE DERIVATIVES PHARMACOLOGICALLY ACTIVE ON THE PERIPHERAL MICROCIRCULATION [J].
MESKINI, N ;
NEMOZ, G ;
OKYAYUZBAKLOUTI, I ;
LAGARDE, M ;
PRIGENT, AF .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (05) :781-788
[19]   PLACEBO-CONTROLLED TRIAL OF THE XANTHINE DERIVATIVE PROPENTOFYLLINE IN DEMENTIA [J].
MOLLER, HJ ;
MAURER, I ;
SALETU, B .
PHARMACOPSYCHIATRY, 1994, 27 (04) :159-165
[20]   PROPENTOFYLLINE AND POSTISCHEMIC BRAIN EDEMA - RELATION TO NA+-K+-ATPASE ACTIVITY [J].
MRSULJA, BB ;
MICIC, DV ;
STEFANOVICH, V .
DRUG DEVELOPMENT RESEARCH, 1985, 6 (04) :339-344